PRMT5 and B-cell non-Hodgkin lymphoma: Aberrant expression of miR-92b and miR-96 is associated with enhanced protein arginine methyltransferase-5 (PRMT5) translation, which is overexpressed in aggressive B-cell non-Hodgkin’s lymphomas, including MCL and diffuse large B-cell lymphoma (DLBCL).